
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Autoimmune encephalitis - antibody testing, tumor workup, first and second-line immunotherapy, and long-term management.">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/autoimmune-encephalitis/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Autoimmune Encephalitis - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#autoimmune-encephalitis" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Autoimmune Encephalitis
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cidp/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    CIDP
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/diabetic-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Diabetic Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-chronic-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS Chronic Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Headache
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Headache
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/migraine/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Migraine
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cluster-headache/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cluster Headache
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/medication-overuse-headache/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Medication Overuse Headache
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_11" >
        
          
          <label class="md-nav__link" for="__nav_3_11" id="__nav_3_11_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Movement Disorders
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_11_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_11">
            <span class="md-nav__icon md-icon"></span>
            
  
    Movement Disorders
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/parkinsons-disease-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Parkinson's Disease - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/essential-tremor/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Essential Tremor
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/restless-legs-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Restless Legs Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_12" >
        
          
          <label class="md-nav__link" for="__nav_3_12" id="__nav_3_12_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Dementia & Cognitive
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_12_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_12">
            <span class="md-nav__icon md-icon"></span>
            
  
    Dementia & Cognitive
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/dementia-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Dementia Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_13" >
        
          
          <label class="md-nav__link" for="__nav_3_13" id="__nav_3_13_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Cranial Neuropathies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_13_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_13">
            <span class="md-nav__icon md-icon"></span>
            
  
    Cranial Neuropathies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bells-palsy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bell's Palsy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/trigeminal-neuralgia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Trigeminal Neuralgia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_14" >
        
          
          <label class="md-nav__link" for="__nav_3_14" id="__nav_3_14_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Intracranial Pressure
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_14_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_14">
            <span class="md-nav__icon md-icon"></span>
            
  
    Intracranial Pressure
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/idiopathic-intracranial-hypertension/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Idiopathic Intracranial Hypertension
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_15" >
        
          
          <label class="md-nav__link" for="__nav_3_15" id="__nav_3_15_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Metabolic & Nutritional
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_15_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_15">
            <span class="md-nav__icon md-icon"></span>
            
  
    Metabolic & Nutritional
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/wernicke-encephalopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Wernicke Encephalopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_16" >
        
          
          <label class="md-nav__link" for="__nav_3_16" id="__nav_3_16_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Syncope & Autonomic
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_16_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_16">
            <span class="md-nav__icon md-icon"></span>
            
  
    Syncope & Autonomic
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/syncope/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Syncope Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_17" >
        
          
          <label class="md-nav__link" for="__nav_3_17" id="__nav_3_17_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_17_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_17">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-graus-2016-diagnostic-criteria-for-autoimmune-encephalitis" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: Graus 2016 Diagnostic Criteria for Autoimmune Encephalitis
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-tumor-screening-by-antibody" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Tumor Screening by Antibody
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-c-treatment-algorithm" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX C: Treatment Algorithm
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-d-prognosis-by-antibody-type" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX D: Prognosis by Antibody Type
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:autoimmune" class="md-tag">autoimmune</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:emergency" class="md-tag">emergency</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:encephalitis" class="md-tag">encephalitis</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:neurocritical-care" class="md-tag">neurocritical-care</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="autoimmune-encephalitis">Autoimmune Encephalitis<a class="headerlink" href="#autoimmune-encephalitis" title="Permanent link">&para;</a></h1>
<p><strong>VERSION:</strong> 1.0
<strong>CREATED:</strong> January 24, 2026
<strong>REVISED:</strong> January 24, 2026
<strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>DIAGNOSIS:</strong> Autoimmune Encephalitis</p>
<p><strong>ICD-10:</strong> G04.81 (Other encephalitis and encephalomyelitis, autoimmune), G04.90 (Encephalitis and encephalomyelitis, unspecified), G13.1 (Other systemic atrophy primarily affecting CNS in neoplastic disease)</p>
<p><strong>SCOPE:</strong> Evaluation and management of autoimmune encephalitis in adults, including antibody-mediated (anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA, etc.) and paraneoplastic encephalitis. Covers diagnostic workup, tumor screening, first-line and second-line immunotherapy, and long-term management. Excludes infectious encephalitis, Hashimoto's encephalopathy (SREAT), and pediatric-specific presentations.</p>
<p><strong>CLINICAL SYNONYMS:</strong> Limbic encephalitis, anti-NMDA receptor encephalitis, paraneoplastic encephalitis, antibody-mediated encephalitis, voltage-gated potassium channel complex encephalitis (VGKC)</p>
<hr />
<p><strong>KEY CLINICAL FEATURES:</strong>
- <strong>Subacute onset:</strong> Days to weeks (usually &lt;3 months)
- <strong>Psychiatric symptoms:</strong> Psychosis, paranoia, personality change, agitation, catatonia
- <strong>Cognitive dysfunction:</strong> Memory impairment (especially short-term), confusion
- <strong>Seizures:</strong> New-onset seizures (often refractory)
- <strong>Movement disorders:</strong> Orofacial dyskinesia, choreoathetosis, dystonia, catatonia
- <strong>Autonomic instability:</strong> Hyperthermia, blood pressure fluctuations, tachycardia, hypoventilation
- <strong>Decreased level of consciousness:</strong> May progress to coma</p>
<p><strong>MAJOR ANTIBODY SYNDROMES:</strong></p>
<table>
<thead>
<tr>
<th>Antibody</th>
<th>Clinical Features</th>
<th>Tumor Association</th>
<th>Demographics</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Anti-NMDAR</strong></td>
<td>Psychiatric, seizures, movement disorder, autonomic instability, coma</td>
<td>Ovarian teratoma (50% in women)</td>
<td>Young women &gt; men</td>
</tr>
<tr>
<td><strong>Anti-LGI1</strong></td>
<td>Faciobrachial dystonic seizures, hyponatremia, memory loss</td>
<td>Thymoma (&lt;10%)</td>
<td>Older adults (&gt;50)</td>
</tr>
<tr>
<td><strong>Anti-CASPR2</strong></td>
<td>Neuromyotonia, limbic encephalitis, Morvan syndrome</td>
<td>Thymoma (20%)</td>
<td>Older men</td>
</tr>
<tr>
<td><strong>Anti-GABA-B</strong></td>
<td>Limbic encephalitis, prominent seizures</td>
<td>SCLC (50%)</td>
<td>Older adults</td>
</tr>
<tr>
<td><strong>Anti-AMPA</strong></td>
<td>Limbic encephalitis, psychiatric symptoms</td>
<td>SCLC, thymoma, breast (65%)</td>
<td>Older adults</td>
</tr>
<tr>
<td><strong>Anti-GAD65</strong></td>
<td>Stiff person, cerebellar, limbic encephalitis</td>
<td>Rare</td>
<td>F &gt; M</td>
</tr>
<tr>
<td><strong>Anti-Hu (ANNA-1)</strong></td>
<td>Limbic encephalitis, sensory neuropathy, cerebellar</td>
<td>SCLC (majority)</td>
<td>Older adults</td>
</tr>
<tr>
<td><strong>Anti-Ma2/Ta</strong></td>
<td>Limbic/brainstem encephalitis, sleep disorder</td>
<td>Testicular, SCLC, breast</td>
<td>Young men (testicular)</td>
</tr>
</tbody>
</table>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<hr />
<div class="admonition danger">
<p class="admonition-title">⚡ TREATABLE CAUSE OF ENCEPHALITIS</p>
<p><strong>Autoimmune encephalitis is treatable but time-sensitive.</strong> Earlier immunotherapy leads to better outcomes. Do not wait for antibody results to start treatment if clinical suspicion is high.</p>
</div>
<div class="admonition warning">
<p class="admonition-title">⚠️ TUMOR SEARCH CRITICAL</p>
<p>Many autoimmune encephalitides are paraneoplastic. <strong>Tumor identification and treatment</strong> are essential for neurological recovery.</p>
</div>
<hr />
<p>═══════════════════════════════════════════════════════════════
SECTION A: ACTION ITEMS
═══════════════════════════════════════════════════════════════</p>
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs">1A. Essential/Core Labs<a class="headerlink" href="#1a-essentialcore-labs" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBC with differential</td>
<td>Infection screen, baseline</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>CMP (BMP + LFTs)</td>
<td>Electrolytes (hyponatremia in LGI1), renal/hepatic function</td>
<td>Na+ &lt;135 suggests LGI1; otherwise normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>TSH</td>
<td>Hashimoto's encephalopathy differential</td>
<td>Normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Blood glucose</td>
<td>Metabolic encephalopathy screen</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>ESR, CRP</td>
<td>Inflammatory markers</td>
<td>Usually normal or mildly elevated</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>PT/INR, PTT</td>
<td>Pre-LP</td>
<td>INR &lt;1.5</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>HIV antibody/antigen</td>
<td>Immunocompromise screen</td>
<td>Negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>RPR/VDRL</td>
<td>Neurosyphilis differential</td>
<td>Negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Urinalysis, urine drug screen</td>
<td>Alternative diagnoses</td>
<td>Negative</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Ammonia</td>
<td>Metabolic encephalopathy</td>
<td>Normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>B12, folate</td>
<td>Metabolic causes of encephalopathy</td>
<td>Normal</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Autoimmune encephalitis panel (serum)</strong></td>
<td>Antibody identification</td>
<td>Identify specific antibody (NMDAR, LGI1, CASPR2, GABA-B, AMPA, GAD65, others)</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td><strong>Paraneoplastic panel (serum)</strong></td>
<td>Tumor-associated antibodies</td>
<td>Identify Hu, Yo, Ri, Ma2/Ta, CV2, amphiphysin</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>TPO antibodies</td>
<td>Hashimoto's encephalopathy</td>
<td>Document if elevated</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Anti-thyroglobulin antibodies</td>
<td>Hashimoto's encephalopathy</td>
<td>Document if elevated</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>ANA, dsDNA</td>
<td>Autoimmune disease screen</td>
<td>Usually negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>ANCA</td>
<td>Vasculitis screen</td>
<td>Negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Tumor markers (CEA, AFP, CA-125, CA 19-9, beta-hCG, PSA)</td>
<td>Occult malignancy</td>
<td>Normal</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Serum protein electrophoresis</td>
<td>Paraproteinemia</td>
<td>Normal</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Quantitative immunoglobulins</td>
<td>Pre-IVIg, immunodeficiency</td>
<td>IgA &gt;7 mg/dL</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Hepatitis B surface antigen</td>
<td>Pre-rituximab screening</td>
<td>Negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cell-based assay for neuronal antibodies</td>
<td>More sensitive than commercial panels</td>
<td>Antibody confirmation</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>VGCC antibodies (P/Q and N-type)</td>
<td>LEMS, cerebellar degeneration</td>
<td>Negative unless paraneoplastic</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>SOX1 antibody</td>
<td>SCLC-associated</td>
<td>Document</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>DPPX antibody</td>
<td>GI symptoms + encephalopathy</td>
<td>Document</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>Neurexin-3 antibody</td>
<td>Encephalitis, seizures</td>
<td>Document</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>IgLON5 antibody</td>
<td>Sleep disorder, brainstem dysfunction</td>
<td>Document</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>Mitochondrial DNA testing</td>
<td>Mitochondrial encephalopathy</td>
<td>Normal</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI brain with and without contrast</td>
<td>STAT</td>
<td>Medial temporal T2/FLAIR hyperintensity (limbic); may be normal in 50%</td>
<td>Hemodynamic instability, pacemaker</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>EEG (routine or continuous)</td>
<td>STAT if seizures or AMS</td>
<td>Extreme delta brush (NMDAR), temporal slowing, seizures</td>
<td>None</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>CT chest/abdomen/pelvis with contrast</td>
<td>Tumor search</td>
<td>Occult malignancy (lung, ovary, testes, thymus)</td>
<td>Contrast allergy, renal impairment</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
</tbody>
</table>
<p><strong>MRI Findings:</strong>
- <strong>Limbic encephalitis:</strong> Medial temporal lobe T2/FLAIR hyperintensity (uni- or bilateral)
- <strong>Anti-NMDAR:</strong> Often normal; may show subtle cortical/subcortical changes
- <strong>May be normal in up to 50%:</strong> Does NOT rule out autoimmune encephalitis</p>
<p><strong>EEG Findings:</strong>
- <strong>Extreme delta brush:</strong> Highly specific for anti-NMDAR encephalitis (seen in ~30%)
- <strong>Temporal slowing:</strong> Common in limbic encephalitis
- <strong>Subclinical seizures:</strong> Frequent; continuous EEG recommended</p>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pelvic ultrasound (women)</td>
<td>If anti-NMDAR positive</td>
<td>Ovarian teratoma</td>
<td>None</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>MRI pelvis with contrast</td>
<td>If US equivocal</td>
<td>Ovarian teratoma</td>
<td>Pacemaker</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Testicular ultrasound (men &lt;50)</td>
<td>If anti-Ma2 or clinical concern</td>
<td>Testicular tumor</td>
<td>None</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>CT or PET-CT chest</td>
<td>Thymoma, lung cancer</td>
<td>Tumor identification</td>
<td>Contrast allergy</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Whole body PET-CT</td>
<td>Occult malignancy search</td>
<td>Any FDG-avid tumor</td>
<td>Hemodynamic instability</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Mammogram</td>
<td>Breast cancer screening</td>
<td>Normal</td>
<td>None</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Continuous EEG (cEEG)</td>
<td>Refractory cases, coma</td>
<td>Nonconvulsive seizures</td>
<td>None</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brain biopsy</td>
<td>Diagnostic uncertainty, refractory</td>
<td>Inflammatory infiltrate</td>
<td>Coagulopathy</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>FDG-PET brain</td>
<td>Clarify extent of involvement</td>
<td>Temporal hypermetabolism</td>
<td>Hemodynamic instability</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
<tr>
<td>Repeat whole body imaging</td>
<td>If initial negative, strong suspicion</td>
<td>Occult tumor</td>
<td>—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">EXT</td>
</tr>
</tbody>
</table>
<h3 id="lumbar-puncture">LUMBAR PUNCTURE<a class="headerlink" href="#lumbar-puncture" title="Permanent link">&para;</a></h3>
<p><strong>Indication:</strong> ALL suspected autoimmune encephalitis</p>
<p><strong>Timing:</strong> URGENT after CT (or proceed directly if no contraindications)</p>
<p><strong>Volume Required:</strong> 15-20 mL (need adequate volume for antibody testing)</p>
<table>
<thead>
<tr>
<th>Study</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Opening pressure</td>
<td>Usually normal</td>
<td>10-20 cmH2O</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Cell count with differential</td>
<td>Lymphocytic pleocytosis</td>
<td>WBC 10-100 (lymphocyte predominant); may be normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Protein</td>
<td>Often mildly elevated</td>
<td>45-100 mg/dL; may be normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Glucose</td>
<td>Usually normal</td>
<td>Normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td><strong>Autoimmune encephalitis panel (CSF)</strong></td>
<td><strong>Critical for diagnosis</strong></td>
<td><strong>Identify neuronal antibodies; CSF more sensitive than serum for some (NMDAR)</strong></td>
<td style="text-align: center;"><strong>STAT</strong></td>
<td style="text-align: center;"><strong>STAT</strong></td>
<td style="text-align: center;">—</td>
<td style="text-align: center;"><strong>STAT</strong></td>
</tr>
<tr>
<td>Oligoclonal bands</td>
<td>Intrathecal synthesis</td>
<td>May be positive</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>IgG index</td>
<td>Intrathecal synthesis</td>
<td>May be elevated</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>HSV PCR</td>
<td>Exclude HSV encephalitis</td>
<td>Negative (but post-HSV autoimmune is possible)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>VZV PCR</td>
<td>Exclude VZV encephalitis</td>
<td>Negative</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Bacterial culture, Gram stain</td>
<td>Exclude bacterial infection</td>
<td>Negative</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Cytology</td>
<td>Carcinomatous meningitis</td>
<td>Negative</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>BioFire ME Panel</td>
<td>Exclude infectious causes</td>
<td>Negative</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<p><strong>CSF Findings in Autoimmune Encephalitis:</strong></p>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Typical Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>Opening pressure</td>
<td>Normal</td>
</tr>
<tr>
<td>WBC</td>
<td>Normal to mild pleocytosis (10-100, lymphocytes)</td>
</tr>
<tr>
<td>Protein</td>
<td>Normal to mildly elevated</td>
</tr>
<tr>
<td>Glucose</td>
<td>Normal</td>
</tr>
<tr>
<td>Oligoclonal bands</td>
<td>May be positive</td>
</tr>
<tr>
<td>Neuronal antibodies</td>
<td>Positive (CSF more sensitive for NMDAR)</td>
</tr>
</tbody>
</table>
<p><strong>CRITICAL:</strong> CSF may be completely normal in autoimmune encephalitis. A normal CSF does NOT rule out the diagnosis.</p>
<p><strong>Special Handling:</strong> Send adequate volume (15-20 mL). CSF autoimmune panel sent to reference lab; results may take 1-2 weeks.</p>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<p><strong>CRITICAL:</strong> Start immunotherapy empirically if clinical suspicion high. Do NOT wait for antibody results (may take 1-2 weeks).</p>
<h3 id="when-to-start-empiric-immunotherapy">When to Start Empiric Immunotherapy<a class="headerlink" href="#when-to-start-empiric-immunotherapy" title="Permanent link">&para;</a></h3>
<p><strong>Start empiric treatment when ALL of the following are met:</strong>
1. Clinical presentation meets criteria for "possible autoimmune encephalitis" (subacute onset, encephalopathy, plus seizures/CSF pleocytosis/MRI findings)
2. Infectious etiologies reasonably excluded (negative CSF bacterial culture/Gram stain, HSV PCR sent or negative)
3. Alternative diagnoses (toxic, metabolic, structural) reasonably excluded</p>
<p><strong>Escalate urgency for empiric treatment if:</strong>
- Severe presentation (ICU admission, status epilepticus, coma)
- Rapidly progressive course
- Classical syndrome (e.g., young woman with psychiatric symptoms + movement disorder → anti-NMDAR)</p>
<p><strong>Reference:</strong> <a href="https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/canadian-consensus-guidelines-for-the-diagnosis-and-treatment-of-autoimmune-encephalitis-in-adults/DC88204486B656B85324E93AF2CCCFC7">Canadian Consensus Guidelines</a>; <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8223680/">Cellucci et al. 2020</a></p>
<h3 id="3a-first-line-immunotherapy">3A. First-Line Immunotherapy<a class="headerlink" href="#3a-first-line-immunotherapy" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Methylprednisolone</td>
<td>IV</td>
<td>First-line immunotherapy</td>
<td>1000 mg daily x 5 days :: IV :: daily x 5 days :: 1000 mg IV daily x 3-5 days; infuse over 1 hour</td>
<td>Active untreated infection, uncontrolled diabetes (relative)</td>
<td>Glucose, BP, psychiatric symptoms, GI bleeding</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>IVIg (immune globulin IV)</td>
<td>IV</td>
<td>First-line immunotherapy</td>
<td>0.4 g/kg/day x 5 days :: IV :: daily x 5 days :: 0.4 g/kg/day IV for 5 days (total 2 g/kg); start slow day 1</td>
<td>IgA deficiency with anti-IgA antibodies; severe renal impairment</td>
<td>Renal function, headache, infusion reactions</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Plasmapheresis (PLEX)</td>
<td>—</td>
<td>First-line immunotherapy</td>
<td>5-7 exchanges over 10-14 days :: — :: QOD :: 5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange</td>
<td>Hemodynamic instability, severe sepsis</td>
<td>BP, electrolytes, coagulation, fibrinogen</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<p><strong>First-Line Strategy:</strong>
- <strong>High-dose steroids + IVIg:</strong> Most common initial approach
- <strong>PLEX:</strong> Alternative or in combination with steroids
- <strong>Combination:</strong> Steroids + IVIg OR Steroids + PLEX often used together
- <strong>Response time:</strong> May take 2-4 weeks; if no improvement, proceed to second-line</p>
<h3 id="3b-second-line-immunotherapy-if-first-line-fails">3B. Second-Line Immunotherapy (If First-Line Fails)<a class="headerlink" href="#3b-second-line-immunotherapy-if-first-line-fails" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rituximab</td>
<td>IV</td>
<td>First-line failure, anti-NMDAR</td>
<td>375 mg/m² weekly x 4 weeks; 1000 mg x 2 doses :: IV :: weekly x 4 or 1000 mg q2wk x 2 :: 375 mg/m² IV weekly x 4 OR 1000 mg IV x 2 doses (2 weeks apart); pre-medicate</td>
<td>Active infection, HBV (screen), live vaccines</td>
<td>Infusion reactions, B-cell counts, immunoglobulins</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Cyclophosphamide</td>
<td>IV</td>
<td>First-line failure, paraneoplastic</td>
<td>750 mg/m² monthly x 6 :: IV :: monthly :: 750 mg/m² IV monthly x 6 cycles; with mesna for bladder protection</td>
<td>Cytopenias, active infection, pregnancy</td>
<td>CBC weekly, renal function, hemorrhagic cystitis</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
</tbody>
</table>
<p><strong>Second-Line Timing:</strong>
- <strong>Standard:</strong> Consider at 2-4 weeks if no response to first-line
- <strong>Critically ill (ICU, coma, refractory status epilepticus):</strong> Consider second-line agents at 1-2 weeks if no improvement, or sooner if rapidly deteriorating
- <strong>Early escalation considerations:</strong> Disease severity, initial treatment response, and relapse risk
- <strong>Practical note:</strong> Given delayed onset of rituximab effect (weeks), continue first-line therapies until clinical improvement observed
- Earlier in severe/refractory cases (persistent coma, ICU-level care)
- Rituximab preferred for anti-NMDAR encephalitis
- Cyclophosphamide often preferred for paraneoplastic encephalitis</p>
<h3 id="3c-tumor-treatment">3C. Tumor Treatment<a class="headerlink" href="#3c-tumor-treatment" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tumor resection (ovarian teratoma)</td>
<td>Surgical</td>
<td>Anti-NMDAR with teratoma</td>
<td>N/A :: — :: :: Surgical removal of ovarian teratoma is CRITICAL for recovery; early surgery improves outcomes</td>
<td>Unstable patient</td>
<td>Post-op neuro status</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Thymectomy</td>
<td>Surgical</td>
<td>Thymoma-associated encephalitis</td>
<td>N/A :: — :: :: Surgical resection of thymoma</td>
<td>Unstable patient</td>
<td>Post-op neuro status</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Oncology treatment</td>
<td>Various</td>
<td>Tumor-associated encephalitis</td>
<td>Per oncology :: — :: :: Treat underlying malignancy per oncology recommendations</td>
<td>—</td>
<td>Per oncology</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<p><strong>CRITICAL:</strong> Tumor removal is essential for neurological recovery in paraneoplastic cases. Early surgery (especially teratoma removal) significantly improves outcomes.</p>
<h3 id="3d-seizure-management">3D. Seizure Management<a class="headerlink" href="#3d-seizure-management" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Levetiracetam</td>
<td>IV/PO</td>
<td>Seizures, seizure prophylaxis</td>
<td>1000 mg BID; 1500 mg BID; 2000 mg BID :: IV/PO :: BID :: Load 1000-2000 mg IV, then 1000-1500 mg BID; may need higher doses</td>
<td>Severe renal impairment (adjust)</td>
<td>Seizure frequency, behavior</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Lacosamide</td>
<td>IV/PO</td>
<td>Adjunctive seizure control</td>
<td>200 mg BID; 300 mg BID :: IV/PO :: BID :: Load 200-400 mg IV, then 200-300 mg BID</td>
<td>PR prolongation, severe cardiac disease</td>
<td>ECG, PR interval</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Valproate</td>
<td>IV/PO</td>
<td>Seizures</td>
<td>20 mg/kg load; 500 mg BID; 750 mg BID :: IV/PO :: load then BID :: Load 20-30 mg/kg IV, then 500-750 mg BID; target level 50-100</td>
<td>Liver disease, mitochondrial disease, pregnancy</td>
<td>LFTs, ammonia, levels</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Lorazepam</td>
<td>IV</td>
<td>Acute seizure termination</td>
<td>2 mg; 4 mg :: IV :: PRN :: 0.1 mg/kg IV (max 4 mg); may repeat x1</td>
<td>Respiratory depression</td>
<td>RR, O2 sat</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Midazolam infusion</td>
<td>IV</td>
<td>Refractory status epilepticus</td>
<td>0.1-0.4 mg/kg/hr :: IV :: continuous :: 0.2 mg/kg bolus, then 0.1-0.4 mg/kg/hr infusion; for refractory seizures</td>
<td>—</td>
<td>EEG, sedation, respiratory</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<h3 id="3e-symptomaticsupportive-care">3E. Symptomatic/Supportive Care<a class="headerlink" href="#3e-symptomaticsupportive-care" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Haloperidol</td>
<td>IV/IM</td>
<td>Agitation, psychosis</td>
<td>2-5 mg q4-6h PRN :: IV/IM :: q4-6h PRN :: 2-5 mg IV/IM q4-6h PRN for severe agitation; avoid in movement disorders</td>
<td>QT prolongation, movement disorders, Parkinson</td>
<td>QTc, EPS</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Quetiapine</td>
<td>PO</td>
<td>Agitation, psychosis (milder)</td>
<td>25 mg BID; 50 mg BID; 100 mg BID :: PO :: BID :: Start 25 mg BID; titrate as needed; lower EPS risk</td>
<td>QT prolongation</td>
<td>QTc, sedation</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Lorazepam</td>
<td>IV/PO</td>
<td>Catatonia, agitation</td>
<td>1 mg q6h; 2 mg q6h :: IV/PO :: q6h :: 1-2 mg IV/PO q6h; often effective for catatonia</td>
<td>Respiratory depression</td>
<td>RR, sedation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Propranolol</td>
<td>PO</td>
<td>Autonomic instability (tachycardia)</td>
<td>10 mg TID; 20 mg TID :: PO :: TID :: 10-20 mg PO TID for tachycardia</td>
<td>Bradycardia, hypotension, asthma</td>
<td>HR, BP</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Clonidine</td>
<td>PO/transdermal</td>
<td>Autonomic instability</td>
<td>0.1 mg BID; 0.1 mg patch weekly :: PO/TD :: BID :: 0.1 mg PO BID or 0.1 mg/24h patch; for hypertension/tachycardia</td>
<td>Hypotension</td>
<td>BP, HR</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Enoxaparin</td>
<td>SC</td>
<td>DVT prophylaxis</td>
<td>40 mg daily :: SC :: daily :: 40 mg SC daily</td>
<td>Active bleeding, coagulopathy</td>
<td>Platelet count</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Famotidine</td>
<td>IV/PO</td>
<td>Stress ulcer prophylaxis</td>
<td>20 mg BID :: IV/PO :: BID :: 20 mg BID if on steroids or intubated</td>
<td>None</td>
<td>GI bleeding</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Insulin</td>
<td>IV/SC</td>
<td>Steroid-induced hyperglycemia</td>
<td>Per sliding scale :: IV/SC :: per protocol :: Target glucose &lt;180 mg/dL</td>
<td>Hypoglycemia</td>
<td>Glucose q4-6h</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<h3 id="3f-long-termmaintenance-immunotherapy">3F. Long-Term/Maintenance Immunotherapy<a class="headerlink" href="#3f-long-termmaintenance-immunotherapy" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mycophenolate mofetil</td>
<td>PO</td>
<td>Maintenance immunosuppression</td>
<td>500 mg BID; 1000 mg BID; 1500 mg BID :: PO :: BID :: Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks</td>
<td>Pregnancy, cytopenias</td>
<td>CBC q2wk x 2 mo, then monthly</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Azathioprine</td>
<td>PO</td>
<td>Maintenance immunosuppression</td>
<td>50 mg daily; 100 mg daily; 150 mg daily :: PO :: daily :: Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT first</td>
<td>TPMT deficiency, pregnancy</td>
<td>CBC weekly x 4, then monthly; LFTs</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Prednisone (oral taper)</td>
<td>PO</td>
<td>Steroid taper</td>
<td>60 mg daily; 40 mg daily; 20 mg daily; 10 mg daily :: PO :: daily :: Taper over weeks to months; individualize based on response</td>
<td>—</td>
<td>Glucose, BP, bone density</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Rituximab (maintenance)</td>
<td>IV</td>
<td>Relapse prevention (NMDAR)</td>
<td>500-1000 mg q6mo :: IV :: q6 months :: 500-1000 mg IV q6 months for 2 years or longer; recheck antibodies</td>
<td>Active infection</td>
<td>B-cell counts, immunoglobulins</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurology consult for diagnosis confirmation, immunotherapy guidance, and antibody interpretation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Neuro-immunology consult for complex cases, second-line therapy decisions, and long-term management</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Oncology consult for tumor workup and treatment if paraneoplastic syndrome identified</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Gynecologic oncology for ovarian teratoma removal which is critical for anti-NMDAR encephalitis recovery</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Critical care consult for ICU admission given autonomic instability, coma, or need for sedation/ventilation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Psychiatry consult for severe psychiatric symptoms, catatonia, or behavioral management in acute phase</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Epilepsy consult for refractory seizures and continuous EEG monitoring guidance</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Physical therapy for mobility assessment and fall prevention given fluctuating weakness and dyskinesias</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Occupational therapy for ADL assessment and cognitive rehabilitation to maximize functional recovery</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Speech therapy for swallow evaluation and communication strategies given dysarthria and aphasia</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
</tr>
<tr>
<td>Neuropsychology for formal cognitive assessment to document deficits and guide rehabilitation</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Social work for discharge planning and family support given prolonged recovery and potential disability</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Return immediately if worsening confusion, seizures, or new symptoms develop (may indicate relapse requiring treatment escalation)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Continue immunotherapy as prescribed even when feeling better; stopping early increases relapse risk</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Report fever or signs of infection promptly as immunosuppression increases infection risk</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Follow seizure precautions including no driving, swimming alone, or heights due to unpredictable seizure risk</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Attend all follow-up appointments as relapses can occur months to years after initial presentation</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Expect that recovery may take months to years; improvement often continues for 2+ years</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Participate in cognitive rehabilitation as this is essential for optimizing recovery from memory and executive deficits</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Contact Autoimmune Encephalitis Alliance (www.aealliance.org) for patient support and educational resources</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Use fall precautions including walker and supervision due to movement disorders and cognitive impairment</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Aspiration precautions including thickened liquids and upright positioning if swallow impaired</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>DVT prophylaxis with SCDs and/or anticoagulation given prolonged immobility risk</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Avoid live vaccines while on immunosuppression; inactivated vaccines are safe and recommended</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Practice infection prevention including hand hygiene and avoiding sick contacts while on immunosuppression</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Continue regular cancer screening for paraneoplastic cases as tumor recurrence can trigger relapse</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Use cognitive pacing with scheduled rest periods to manage post-encephalitis fatigue</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not drive until cleared by neurology due to seizure risk and cognitive impairment</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
</tr>
</tbody>
</table>
<hr />
<p>═══════════════════════════════════════════════════════════════
SECTION B: REFERENCE (Expand as Needed)
═══════════════════════════════════════════════════════════════</p>
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>HSV encephalitis</td>
<td>Acute, temporal lobe predominant, hemorrhagic</td>
<td>MRI temporal, HSV PCR</td>
</tr>
<tr>
<td>Other viral encephalitis</td>
<td>Fever, CSF pleocytosis, specific epidemiology</td>
<td>Viral PCRs</td>
</tr>
<tr>
<td>Bacterial meningitis</td>
<td>Acute, toxic, PMN predominant CSF</td>
<td>CSF Gram stain, culture</td>
</tr>
<tr>
<td>Tuberculous meningitis</td>
<td>Subacute, basilar, low glucose</td>
<td>CSF AFB, PCR, ADA</td>
</tr>
<tr>
<td>Neurosyphilis</td>
<td>Risk factors, varied presentations</td>
<td>RPR, CSF VDRL, FTA-ABS</td>
</tr>
<tr>
<td>Primary CNS lymphoma</td>
<td>Immunocompromised, periventricular</td>
<td>MRI pattern, CSF cytology</td>
</tr>
<tr>
<td>Glioblastoma</td>
<td>Focal deficits, ring-enhancing mass</td>
<td>MRI, biopsy</td>
</tr>
<tr>
<td>Creutzfeldt-Jakob disease</td>
<td>Rapid dementia, myoclonus, DWI restriction</td>
<td>MRI pattern, 14-3-3, RT-QuIC</td>
</tr>
<tr>
<td>Hashimoto's encephalopathy (SREAT)</td>
<td>Elevated TPO, responds to steroids</td>
<td>TPO antibodies, exclusion</td>
</tr>
<tr>
<td>Psychiatric illness (primary)</td>
<td>No CSF/MRI changes, prior history</td>
<td>Normal workup, psychiatric evaluation</td>
</tr>
<tr>
<td>Toxic/metabolic encephalopathy</td>
<td>Drug/toxin exposure, metabolic derangement</td>
<td>Toxicology, metabolic panel</td>
</tr>
<tr>
<td>ADEM</td>
<td>Post-infectious, multifocal white matter</td>
<td>MRI pattern (multifocal), monophasic</td>
</tr>
<tr>
<td>CNS vasculitis</td>
<td>Multifocal strokes, systemic symptoms</td>
<td>Angiography, vessel wall MRI</td>
</tr>
<tr>
<td>Wernicke encephalopathy</td>
<td>Alcoholism, classic triad, mammillary bodies</td>
<td>Thiamine trial, MRI</td>
</tr>
<tr>
<td>Seizure-related (postictal)</td>
<td>Seizure witnessed, resolves with time</td>
<td>EEG, observation</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurological exam (GCS, MMSE)</td>
<td>q4-8h initially</td>
<td>Improving</td>
<td>Re-evaluate treatment, escalate</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Seizure activity</td>
<td>Continuous if cEEG; q4h assessment</td>
<td>No seizures</td>
<td>Escalate antiepileptic therapy</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Vital signs (autonomic function)</td>
<td>q1-4h</td>
<td>Stable HR, BP, temp</td>
<td>Supportive care, ICU if unstable</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Blood glucose</td>
<td>q6h if on steroids</td>
<td>&lt;180 mg/dL</td>
<td>Insulin adjustment</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Renal function</td>
<td>q24-48h during IVIg</td>
<td>Cr stable</td>
<td>Hydration, adjust IVIg rate</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Serum sodium</td>
<td>q12-24h (especially LGI1)</td>
<td>135-145 mEq/L</td>
<td>Fluid restriction if hyponatremic</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">STAT</td>
</tr>
<tr>
<td>Antibody titers (serum/CSF)</td>
<td>q3-6 months</td>
<td>Decreasing</td>
<td>Consider treatment escalation</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>Tumor surveillance</td>
<td>Per oncology</td>
<td>No recurrence</td>
<td>Oncology management</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>B-cell counts (if on rituximab)</td>
<td>Before each infusion</td>
<td>Adequate depletion</td>
<td>Adjust dosing interval</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">—</td>
</tr>
<tr>
<td>CBC (if on immunosuppression)</td>
<td>q1-4 weeks</td>
<td>Normal counts</td>
<td>Hold medication, infection workup</td>
<td style="text-align: center;">—</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>ICU admission</strong></td>
<td>GCS &lt;12; refractory seizures; autonomic instability; need for intubation; coma; severe psychiatric symptoms requiring restraint</td>
</tr>
<tr>
<td><strong>Step-down/telemetry</strong></td>
<td>GCS 12-14; controlled seizures; stable autonomic function; receiving immunotherapy</td>
</tr>
<tr>
<td><strong>General floor</strong></td>
<td>GCS 15; stable; no seizures; able to participate in therapies; can complete immunotherapy</td>
</tr>
<tr>
<td><strong>Acute rehabilitation</strong></td>
<td>Significant cognitive or motor deficits; requires intensive therapy; medically stable</td>
</tr>
<tr>
<td><strong>Discharge home</strong></td>
<td>Significant improvement; safe swallow; adequate support; outpatient immunotherapy arranged; neurology follow-up scheduled</td>
</tr>
<tr>
<td><strong>Long-term care</strong></td>
<td>Severe persistent deficits; unable to live independently</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>First-line immunotherapy (steroids, IVIg, PLEX)</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/23290630/">Titulaer et al. Lancet Neurol 2013</a></td>
</tr>
<tr>
<td>Early immunotherapy improves outcomes</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/23290630/">Titulaer et al. Lancet Neurol 2013</a></td>
</tr>
<tr>
<td>Second-line therapy (rituximab, cyclophosphamide)</td>
<td>Class III, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/31326280/">Dalmau et al. Lancet Neurol 2019</a></td>
</tr>
<tr>
<td>Tumor removal essential for recovery</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/23290630/">Titulaer et al. Lancet Neurol 2013</a></td>
</tr>
<tr>
<td>CSF more sensitive than serum for NMDAR</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/24275432/">Gresa-Arribas et al. Lancet Neurol 2014</a></td>
</tr>
<tr>
<td>Extreme delta brush in anti-NMDAR</td>
<td>Class III, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/22966581/">Schmitt et al. Neurology 2012</a></td>
</tr>
<tr>
<td>LGI1 associated with hyponatremia and FBDS</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/20833645/">Irani et al. Brain 2010</a></td>
</tr>
<tr>
<td>Diagnostic criteria for autoimmune encephalitis</td>
<td>Consensus Guidelines</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/26906964/">Graus et al. Lancet Neurol 2016</a></td>
</tr>
<tr>
<td>Long-term outcomes and relapse risk</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/23290630/">Titulaer et al. Lancet Neurol 2013</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 24, 2026)</strong>
- Initial template creation
- Comprehensive antibody syndrome table
- First and second-line immunotherapy protocols
- Tumor screening guidance
- Seizure and autonomic management
- Long-term maintenance therapy</p>
<hr />
<h2 id="appendix-a-graus-2016-diagnostic-criteria-for-autoimmune-encephalitis">APPENDIX A: Graus 2016 Diagnostic Criteria for Autoimmune Encephalitis<a class="headerlink" href="#appendix-a-graus-2016-diagnostic-criteria-for-autoimmune-encephalitis" title="Permanent link">&para;</a></h2>
<p><strong>Possible Autoimmune Encephalitis (all 3 required):</strong>
1. Subacute onset (&lt;3 months) of working memory deficits, altered mental status, or psychiatric symptoms
2. At least ONE of:
   - New focal CNS findings
   - Seizures not explained by prior seizure disorder
   - CSF pleocytosis (&gt;5 WBC/μL)
   - MRI features suggestive of encephalitis
3. Reasonable exclusion of alternative causes</p>
<p><strong>Definite Autoimmune Encephalitis:</strong>
- Possible autoimmune encephalitis PLUS
- Positive neuronal antibody (serum or CSF)</p>
<p><strong>Probable Anti-NMDAR Encephalitis (all 3 required):</strong>
1. Rapid onset (&lt;3 months) of at least 4 of:
   - Abnormal behavior or cognitive dysfunction
   - Speech dysfunction
   - Seizures
   - Movement disorder, dyskinesias, or rigidity
   - Decreased level of consciousness
   - Autonomic dysfunction or central hypoventilation
2. At least ONE of:
   - Abnormal EEG
   - CSF pleocytosis or oligoclonal bands
3. Reasonable exclusion of alternative causes</p>
<hr />
<h2 id="appendix-b-tumor-screening-by-antibody">APPENDIX B: Tumor Screening by Antibody<a class="headerlink" href="#appendix-b-tumor-screening-by-antibody" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Antibody</th>
<th>Primary Tumor</th>
<th>Screening</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Anti-NMDAR</strong></td>
<td>Ovarian teratoma (women)</td>
<td>Pelvic US → MRI pelvis if negative; repeat q6mo x 2 years</td>
</tr>
<tr>
<td><strong>Anti-LGI1</strong></td>
<td>Thymoma (rare)</td>
<td>CT chest</td>
</tr>
<tr>
<td><strong>Anti-CASPR2</strong></td>
<td>Thymoma (~20%)</td>
<td>CT chest</td>
</tr>
<tr>
<td><strong>Anti-GABA-B</strong></td>
<td>SCLC (~50%)</td>
<td>CT chest; PET-CT if negative</td>
</tr>
<tr>
<td><strong>Anti-AMPA</strong></td>
<td>SCLC, thymoma, breast</td>
<td>CT chest/abdomen; mammogram; PET-CT</td>
</tr>
<tr>
<td><strong>Anti-Hu (ANNA-1)</strong></td>
<td>SCLC (~80%)</td>
<td>CT chest; PET-CT if negative</td>
</tr>
<tr>
<td><strong>Anti-Yo</strong></td>
<td>Ovarian, breast</td>
<td>Pelvic US, mammogram, CT</td>
</tr>
<tr>
<td><strong>Anti-Ma2/Ta</strong></td>
<td>Testicular (young men), SCLC</td>
<td>Testicular US, CT chest</td>
</tr>
<tr>
<td><strong>Anti-CV2/CRMP5</strong></td>
<td>SCLC, thymoma</td>
<td>CT chest</td>
</tr>
<tr>
<td><strong>Anti-amphiphysin</strong></td>
<td>Breast, SCLC</td>
<td>Mammogram, CT chest</td>
</tr>
</tbody>
</table>
<p><strong>If initial screening negative but paraneoplastic suspected:</strong>
- Repeat imaging in 3-6 months
- Consider whole-body PET-CT
- Continue surveillance for at least 5 years</p>
<hr />
<h2 id="appendix-c-treatment-algorithm">APPENDIX C: Treatment Algorithm<a class="headerlink" href="#appendix-c-treatment-algorithm" title="Permanent link">&para;</a></h2>
<div class="highlight"><pre><span></span><code>SUSPECTED AUTOIMMUNE ENCEPHALITIS
              │
              ▼
┌─────────────────────────────┐
│ 1. Exclude infections (HSV, │
│    bacterial, etc.)         │
│ 2. Send antibody panels     │
│    (serum AND CSF)          │
│ 3. MRI brain, EEG           │
│ 4. CT body for tumor        │
└─────────────────────────────┘
              │
              ▼
    High clinical suspicion?
         /          \
       YES           NO
        │             │
        ▼             ▼
┌──────────────┐  Wait for
│ START        │  antibody
│ FIRST-LINE:  │  results
│ • IV steroids│
│ • IVIg       │
│ • ± PLEX     │
└──────────────┘
        │
        ▼
   Response at 2-4 weeks?
         /          \
       YES           NO
        │             │
        ▼             ▼
┌──────────────┐ ┌──────────────┐
│ Continue     │ │ SECOND-LINE: │
│ maintenance  │ │ • Rituximab  │
│ therapy      │ │ • ± Cyclophos│
└──────────────┘ └──────────────┘
        │             │
        ▼             ▼
   TUMOR FOUND?   TUMOR FOUND?
        │             │
       YES           YES
        │             │
        ▼             ▼
   ┌─────────────────────┐
   │  TUMOR TREATMENT    │
   │  (Surgery, chemo,   │
   │   radiation)        │
   │  ESSENTIAL FOR      │
   │  NEUROLOGICAL       │
   │  RECOVERY           │
   └─────────────────────┘
</code></pre></div>
<hr />
<h2 id="appendix-d-prognosis-by-antibody-type">APPENDIX D: Prognosis by Antibody Type<a class="headerlink" href="#appendix-d-prognosis-by-antibody-type" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Antibody</th>
<th>Outcome</th>
<th>Relapse Rate</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Anti-NMDAR</strong></td>
<td>Good with treatment (80% significant recovery)</td>
<td>12-25%</td>
<td>Better if teratoma removed; relapses respond to treatment</td>
</tr>
<tr>
<td><strong>Anti-LGI1</strong></td>
<td>Good (70-80% respond)</td>
<td>20-35%</td>
<td>Cognitive deficits may persist; hyponatremia improves</td>
</tr>
<tr>
<td><strong>Anti-CASPR2</strong></td>
<td>Moderate to good</td>
<td>Variable</td>
<td>May have associated neuromyotonia</td>
</tr>
<tr>
<td><strong>Anti-GABA-B</strong></td>
<td>Moderate (depends on tumor)</td>
<td>Low if tumor controlled</td>
<td>Prognosis linked to tumor</td>
</tr>
<tr>
<td><strong>Anti-AMPA</strong></td>
<td>Moderate to poor</td>
<td>High (&gt;50%)</td>
<td>Often paraneoplastic; tumor treatment important</td>
</tr>
<tr>
<td><strong>Anti-Hu</strong></td>
<td>Poor</td>
<td>Low (progressive)</td>
<td>Usually paraneoplastic; neurological deficits often irreversible</td>
</tr>
<tr>
<td><strong>Anti-Yo</strong></td>
<td>Poor</td>
<td>Low (progressive)</td>
<td>Cerebellar degeneration usually irreversible</td>
</tr>
<tr>
<td><strong>Anti-Ma2</strong></td>
<td>Moderate</td>
<td>Variable</td>
<td>Better if testicular tumor found and treated</td>
</tr>
</tbody>
</table>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>